Theranos is laying off 41% of its staff

Theranos is going through another round of layoffs.

Bloomberg reports that the blood-testing company is laying off 41% of its staff. 

In October, Theranos closed its clinical labs, letting go of about 340 people. This round will add another 155 people to that total, with 220 remaining, according to Bloomberg.

In addition to the layoffs, Theranos also sold its Palo Alto offices, the San Francisco Business Times reported Wednesday.

The remaining staff will focus on the company's miniLab technology.

Business Insider has reached out to Theranos for comment.